Abstract
We conducted an annually bloodstream infection (BSI) survey into hospitals overlapping the Centre France region (2.6 million). Since 2005, the incidence of BSIs associated with ESBL-producing E. coli (ESBLEc) increased.
Highlights
We conducted an annually bloodstream infection (BSI) survey into hospitals overlapping the Centre France region (2.6 million)
Clinical features of ESBL-producing E. coli responsible for bloodstream infections in French patients and molecular characterization of isolates
Most ESBLEC were resistant to fluoroquinolones (79%), SXT/TMP (63%)
Summary
We conducted an annually bloodstream infection (BSI) survey into hospitals overlapping the Centre France region (2.6 million). Clinical features of ESBL-producing E. coli responsible for bloodstream infections in French patients and molecular characterization of isolates Introduction We conducted an annually bloodstream infection (BSI) survey into hospitals overlapping the Centre France region (2.6 million). Since 2005, the incidence of BSIs associated with ESBL-producing E. coli (ESBLEc) increased.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
